News

NTI Endorses Biosecurity Modernization and Innovation Act of 2026

NTI endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026, led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). This bill creates an important opportunity to incentivize a safe and secure U.S. bioeconomy through strengthened biosecurity policy.

“The Biosecurity Modernization and Innovation Act represents a critical opportunity to embed biosecurity into the foundation of America’s strong and growing bioeconomy. By modernizing oversight and fostering collaboration across government, industry, and academia, this legislation helps ensure that scientific and technological progress will strengthen—not jeopardize—national and global security.”

— Hayley Anne Severance, acting vice president, NTI | bio

The legislation advances three core objectives essential to safeguarding innovation:

  • Strengths DNA synthesis sequence and customer screening as a near-term risk-reduction measure
  • Establishes an innovation hub within the U.S. government that brings together commercial, academic, and government stakeholders to develop, test, and deploy real-world solutions that embed biosecurity by design
  • Streamlines and strengthens federal oversight of dual-use bioscience and biotechnology research and development to protect against accidental or deliberate harmful activities, forming core pillars of a comprehensive national biosafety and biosecurity strategy.

The bill offers solutions to close gaps in U.S. biotechnology oversight and aligns closely with NTI | bio recommendations for Congressional action. By consolidating and modernizing fragmented approaches to biosecurity and biosafety, the legislation will enable responsible scientific progress, reinforce U.S. biotechnology leadership, and strengthen national and global security.

Stay Informed

Sign up for our newsletter to get the latest on nuclear and biological threats.

Sign Up

NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur

News

NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur

NTI | bio experts will take part in several GHS2026 sessions, including a preview of findings from the forthcoming Africa Health Security (AHS) Index and a timely discussion on strengthening health security partnerships amid declining resources.


NTI at the Munich Security Conference: Advancing a Safer Future

News

NTI at the Munich Security Conference: Advancing a Safer Future

The Nuclear Threat Initiative (NTI) joined world leaders and policymakers at the 2026 Munich Security Conference (MSC), where NTI President and CEO Christine E. Wormuth and colleagues hosted events focused on reducing nuclear, biological, and emerging technology threats imperiling humanity.


NTI and CACDA Issue Joint Statement Calling for Stronger Biosecurity and Responsible AI-Biotechnology Innovation

News

NTI and CACDA Issue Joint Statement Calling for Stronger Biosecurity and Responsible AI-Biotechnology Innovation

Amid rapid advances in bioscience and as artificial intelligence reshapes global technological capabilities, the Nuclear Threat Initiative (NTI) and the China Arms Control and Disarmament Association (CACDA) are jointly calling for action to strengthen biosecurity and oversight and engage in responsible practices to prevent accidents or misuse.


See All News

Close

My Resources

Subscribe to NTI

Sign up for regular updates on innovative, real-world solutions to existential threats.

Get Updates